Continuing increase in mesothelioma mortality in Britain, The Lancet, vol.345, issue.8949, pp.535-544, 19954. ,
DOI : 10.1016/S0140-6736(95)90462-X
Future trends in mortality of French men from mesothelioma, Occupational and Environmental Medicine, vol.57, issue.7, pp.488-94, 2000. ,
DOI : 10.1136/oem.57.7.488
Evolution of pleural 601 cancers and malignant pleural mesothelioma incidence in France between, Int J 602 Cancer, vol.126, issue.1, pp.232-240, 1980. ,
Pleural plaques and the risk 605 of pleural mesothelioma, J Natl Cancer Inst Feb, vol.20105, issue.4, pp.293-301, 2013. ,
Occupations and 608 industries in France at high risk for pleural mesothelioma: a population-based case-control study, Am J Ind Med, vol.60953, issue.12, pp.1207-1226, 1998. ,
612 Attributable risk in men in two French case-control studies on mesothelioma and asbestos, Eur J 613 Epidemiol, 0614. ,
Programme national de 615 surveillance du mésothéliome ? Principaux résultats 1998-2006. Saint-Maurice (Fra) : Institut de 616 veille sanitaire, 2009. ,
Compensation of pleural mesothelioma in France: 21 ,
The French National Mesothelioma Surveillance Program, Occupational and Environmental Medicine, vol.63, issue.6, pp.390-395, 2006. ,
DOI : 10.1136/oem.2005.023200
Pathology of malignant mesothelioma; An update of the International 626 ,
Guidelines for Pathologic Diagnosis of 630 Malignant Mesothelioma: 2012 Update of the Consensus Statement from the International 631 Mesothelioma Interest Group, Arch Pathol Lab Med, vol.632, issue.12, p.633, 2012. ,
Guidelines for 634 pathologic diagnosis of malignant mesothelioma: a consensus statement from the International 635 Mesothelioma Interest Group, Arch Pathol Lab Med, vol.133, issue.8, pp.1317-1348, 2009. ,
Recommendations and quality control in immunohistochemistry, Ann Pathol ,
648 Lymphohistiocytoid variant of malignant mesothelioma of the pleura: A series of 22 cases, Am J, p.649 ,
Which criteria for the anatomopathologic diagnosis of malignant pleural 652 mesothelioma?]. Rev Mal Respir, pp.11-37, 2006. ,
Mesopath group. Well-differentiated papillary mesothelioma of the pleura: a series of 24 cases, p.655 ,
International Association for the Study of Lung Cancer International 658 Staging Committee and the International Mesothelioma Interest Group. Recommendations for 659 uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus 660 report of the international association for the study of lung cancer international staging 661 committee and the international mesothelioma interest group, J Thorac Oncol, 2011. ,
Molecular classification of malignant pleural mesothelioma: Identification ofa poor 666 prognosis subgroup linked to the epithelial-to-mesenchymal transition. Clinical Cancer Research 667 accepté. 668 21 ,
Prognostic significance of 670 p16/cdkn2a loss in pleural malignant mesotheliomas. Virchows Arch, pp.627-662, 2008. ,
EGFR and PDGFR differentially 673 promote growth in malignant epithelioid mesothelioma of short and long term survivors, Thorax, vol.67463, issue.4, pp.345-51, 2008. ,
Molecular changes in 676 mesothelioma with an impact on prognosis and treatment, Arch Pathol Lab Med, 2012. ,
SYT-SSX fusion is absent in sarcomatoid mesothelioma allowing its distinction from synovial sarcoma of the pleura, Modern Pathology, vol.14, issue.6, pp.617-638, 2007. ,
DOI : 10.1038/modpathol.3800775
Plasma cell membrane localization of c-MET predicts longer survival 683 in patients with malignant mesothelioma: a series of 157 cases from the MESOPATH Group, J, vol.684 ,
Differential 688 mutation profiles and similar intronic TP53 polymorphisms in asbestos-related lung cancer and 689 pleural mesothelioma, Mutagenesis, 2013. ,